Maxcyte (MXCT) Asset Utilization Ratio (2021 - 2026)

Maxcyte (MXCT) has reported Asset Utilization Ratio for 6 consecutive years, with 0.16 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Asset Utilization Ratio rose 3.01% year-over-year to 0.16 in Q2 2026; TTM through Jun 2026 was 0.16, a 3.01% increase from a year earlier, with the FY2025 full-year figure at 0.15, down 1.78% from the prior year.
• Asset Utilization Ratio was 0.16 for Q2 2026 at Maxcyte, up from 0.16 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.18 in Q3 2024 and troughed at 0.14 in Q1 2022.
• A 5-year average of 0.16 and a median of 0.16 in 2024 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio decreased 16.22% in 2022 and grew 28.92% in 2024, its largest moves.
• Over 5 years, Asset Utilization Ratio stood at 0.15 in 2022, then dropped by 0.08% to 0.15 in 2023, then grew by 2.55% to 0.16 in 2024, then grew by 0.32% to 0.16 in 2025, then increased by 3.15% to 0.16 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.16 (Q2 2026), 0.16 (Q1 2026), and 0.16 (Q4 2025), per Business Quant data.